CRISPR

The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.

The tests are designed to detect viral RNA in individual respiratory specimens, while BayCare's tests can be used with pooled samples.

The money will be used for research and development, building a clinical laboratory network, and seeking regulatory approval.

The kit, which received EUA from the FDA in May, will be used to test clinical samples from patients at D-HH member hospitals.

The seven technologies feature different methods, including CRISPR and microfluidics, and can be performed in many settings and with a variety of sample types.